Terminal latency index in polyneuropathy with IgM paraproteinemia and anti-MAG antibody

被引:42
作者
Cocito, D
Isoardo, G
Ciaramitaro, P
Migliaretti, G
Pipieri, A
Barbero, P
Cucci, A
Durelli, L
机构
[1] Univ Turin, Dipartimento Neurosci, Unit Operat Neurofisiol Clin, I-10126 Turin, Italy
[2] Univ Turin, Dipartimento Neurosci, Clin Neurol 1, I-10126 Turin, Italy
[3] Univ Turin, Dipartimento Sanita Pubbl & Microbiol, Unita Operat Stat, I-10126 Turin, Italy
关键词
anti-MAG antibody; chronic inflammatory demyelinating; polyneuropathy; paraproteinemia; terminal latency index;
D O I
10.1002/mus.1145
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP) are met by the polyneuropathy associated with immunoglobulin M (IgM) paraproteinemia and anti-myelin-associated glycoprotein (MAG) antibody (MAG-CIDP). However, MAG-CIDP differs from other types of CIDP, mainly in its poorer response to treatment. The utility of terminal latency index (TLI) as an electrophysiological marker for MAG-CIDP has been debated. In this study we confirmed its diagnostic usefulness and evaluated TLI threshold values for motor nerves investigated in routine nerve conduction studies. Median, ulnar, peroneal, and tibial TLIs of 11 subjects with MAG-CIDP, 18 with CIDP, and 76 healthy controls were compared, and threshold values for MAG-CIDP evaluated as the lowest value with a likelihood ratio higher than 10. Mean TLI values and TLIs of all but the peroneal nerve were significantly lower in MAG-CIDP. Median nerve TLI of 0.26 and ulnar nerve TLI of 0.33 were identified as the threshold TLI values for MAG-CIDP. (C) 2001 John Wiley & Sons, Inc.
引用
收藏
页码:1278 / 1282
页数:5
相关论文
共 20 条
[1]  
Amato AA, 1996, MUSCLE NERVE, V19, P16, DOI 10.1002/(SICI)1097-4598(199601)19:1<16::AID-MUS3>3.0.CO
[2]  
2-B
[3]  
CORNBLATH DR, 1991, NEUROLOGY, V41, P617
[4]   Waldenstrom's macroglobulinemia: Clinical features, complications, and management [J].
Dimopoulos, MA ;
Panayiotidis, P ;
Moulopoulos, LA ;
Sfikakis, P ;
Dalakas, M .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) :214-226
[5]  
Ellie E, 1996, J NEUROL, V243, P34
[6]   USERS GUIDES TO THE MEDICAL LITERATURE .3. HOW TO USE AN ARTICLE ABOUT A DIAGNOSTIC-TEST .B. WHAT ARE THE RESULTS AND WILL THEY HELP ME IN CARING FOR MY PATIENTS [J].
JAESCHKE, R ;
GUYATT, GH ;
SACKETT, DL ;
GUYATT, G ;
BASS, E ;
BRILLEDWARDS, P ;
BROWMAN, G ;
COOK, D ;
FARKOUH, M ;
GERSTEIN, H ;
HAYNES, B ;
HAYWARD, R ;
HOLBROOK, A ;
JUNIPER, E ;
LEE, H ;
LEVINE, M ;
MOYER, V ;
NISHIKAWA, J ;
OXMAN, A ;
PATEL, A ;
PHILBRICK, J ;
RICHARDSON, WS ;
SAUVE, S ;
SACKETT, D ;
SINCLAIR, J ;
TROUT, KS ;
TUGWELL, P ;
TUNIS, S ;
WALTER, S ;
WILSON, M .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (09) :703-707
[7]   DISTAL ACCENTUATION OF CONDUCTION SLOWING IN POLYNEUROPATHY ASSOCIATED WITH ANTIBODIES TO MYELIN-ASSOCIATED GLYCOPROTEIN AND SULFATED GLUCURONYL PARAGLOBOSIDE [J].
KAKU, DA ;
ENGLAND, JD ;
SUMNER, AJ .
BRAIN, 1994, 117 :941-947
[8]   Distal acquired demyelinating symmetric neuropathy [J].
Katz, JS ;
Saperstein, DS ;
Gronseth, G ;
Amato, AA ;
Barohn, RJ .
NEUROLOGY, 2000, 54 (03) :615-620
[9]  
Kimura J., 1989, ELECTRODIAGNOSIS DIS, V2nd ed., P103
[10]   Chronic dysimmune demyelinating polyneuropathy: A clinical and electrophysiological study of 93 patients [J].
Maisonobe, T ;
Chassande, B ;
Verin, M ;
Jouni, M ;
Leger, JM ;
Bouche, P .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1996, 61 (01) :36-42